Stock Price Quote

BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE142.10-1.55 (-1.08 %)
PREV CLOSE ( ) 143.65
OPEN PRICE ( ) 140.00
BID PRICE (QTY) 141.00 (12)
OFFER PRICE (QTY) 142.15 (21)
VOLUME 704
TODAY'S LOW / HIGH ( )139.90 144.00
52 WK LOW / HIGH ( )10.24 195.95
NSE141.95-0.8 (-0.56 %)
PREV CLOSE( ) 142.75
OPEN PRICE ( ) 144.50
BID PRICE (QTY) 141.15 (34)
OFFER PRICE (QTY) 142.00 (5)
VOLUME 4813
TODAY'S LOW / HIGH( ) 140.50 144.50
52 WK LOW / HIGH ( )21.3 233.55
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995
Management Info
Bafna Mahaveer Chand - Chairman - Managing Director
Registered Office

Address Bafna Towers,New No 68, Old No.299,Thambu Chetty Street,
Chennai,
Tamil Nadu-600001

Phone 044- 25267517/25270992

Email cs@bafnapharma.com

Website www.bafnapharma.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE, MCX

NEWS

04May Uttam Sugar Mills, JSW Energy and Bafn
Uttam Sugar Mills has installed and implemented the ‘Incineration Boiler..
04May Bafna Pharmaceuticals gets UK-MHRA app
Bafna Pharmaceuticals has added two fully automated packaging lines to i..
04May Bafna Pharmaceuticals zooms on getting
Bafna Pharmaceuticals is currently trading at Rs. 135.15, up by 6.40 poi..
03May Company Update- United Kingdom (UK)-
We would like to update you on the following:- The Company has added..
18Mar Sub.
We would like to submit that the Company has not made any material annou..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit8.99999999999999-252.04
Gross Profit 8.99999999999999 -252.04
Operating Profit 22.4814.85
Net Sales 174.75424.72

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7814.95 (1.26%)
M.Cap ( in Cr)17985.76
Torrent Pharma (BSE)
peergroup  2955.65 (2.63%)
M.Cap ( in Cr)50058.71
Abbott India (BSE)
peergroup  16384.00 (0.37%)
M.Cap ( in Cr)34867.98
Astrazeneca Pharma I (BSE)
peergroup  3818.80 (1.07%)
M.Cap ( in Cr)9606.00
Albert David (BSE)
peergroup  532.80 (7.60%)
M.Cap ( in Cr)294.15

Shareholding Pattern

PROMOTERS 91.74%
NON-INSTITUTION 8.26%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 142.1. Its current market capitalisation stands at Rs 330.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 424.73 Cr and Total Income of Rs.427.28 Cr. The company's management includes Atul Sachdeva, Ravichandran Chitra, Akilapriya Chandrashekar Raju, Palamadi Krishnan Sundaresan, Jitendra Kumar Pal, B Kamlesh Kumar, Shanmugam Hemalatha, Bafna Mahaveer Chand.

It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPH and ISIN of INE878I01022. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)